Trending...
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 176
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 124
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
Media Contact: LARA Communications 517-335-LARA (5272)
Email: mediainfo@michigan.gov
January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.
All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.
More on Michimich.com
This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:
Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)
Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415
Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416
Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.
Email: mediainfo@michigan.gov
January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.
All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.
More on Michimich.com
- Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
- Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
- CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
- Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
- Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:
Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)
Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415
Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416
Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.
0 Comments
Latest on Michimich.com
- Boondocking Magazine Expands FREE Digital Access for Off-Grid Camping Community
- Sterling Heights Resident Survey Shows Strong Approval of Quality of Life and City Services
- Sterling Heights Introduces First-Ever Little Free Sled Library at Delia Park
- Sterling Heights: Beginner 2-5-3.0 Level
- Sterling Heights: Dodge Park Ice Rink Opening Day
- Planet Fitness Partners With Toys For Tots To Bring Holiday Joy To Livingston County Families With F
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- Sterling Advisory Group Celebrates Two-Year Anniversary
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- Japanese Martial Arts Association Explains the Practice of Meditation
- A&D PLM Action Group Validates Digital Twin-Digital Thread Investment Value in Benchmark Report
- Discover Strength and Roots in Libaax with Cedric Muhikira
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona